Home / Publication / Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

論文

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Author(s): Diana Clarke, Mark Mirochnick, Edward Acosta, Edmund Capparelli, Anne Chain, Hedy Teppler, Betsy Smith, Jos Lommerse

Year: 2019年12月1日

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Building PK/PD Workflows with Cloud and AI – APAC Webinar

日本における小児・希少疾患領域のドラッグ・ロス解消に向けて

Phoenix Roadshow 2025 – Copenhagen

The Reference-scaled Average Bioequivalence (RSABE) Approach

メルマガ登録

クイックアクセス

ソリューション

お問合せ